Inhibition of lactate dehydrogenase A by microRNA34a resensitizes colon cancer cells to 5fluorouracil

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 577-582

Spandidos Publications

Access to resources Recommend Favorite

Mechanism of action of a tyrphostin, 3,4-dihydroxy-α-cyanothiocinnamamide, in breast cancer cell growth inhibition involves the suppression of cyclin B1 and the functional activity of cyclin B1/p34cdc2 complex

By Faaland C.A.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 1, 1997-05 ,pp. : 47-56

Springer Publishing Company

Access to resources Recommend Favorite

5-Fluorouracil and cisplatin in the treatment of advanced oral cancer

By Andreadis C.   Vahtsevanos K.   Sidiras T.   Thomaidis I.   Antoniadis K.   Mouratidou D.  

Oral Oncology, Vol. 39, Iss. 4, 2003-06 ,pp. : 380-385

Elsevier

Access to resources Recommend Favorite

Phase II trial of cisplatin, 5-fluorouracil, and interferon- -2B as first line treatment of advanced urothelial cancer

By Bazarbashi S.   Pai C.   Raja M.A.   Rahal M.   Ezzat A.   Hanash K.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 185-189

Elsevier

Access to resources Recommend Favorite

Prognostic significance of p34 cdc2 expression in tongue squamous cell carcinoma

By Wada S.   Yue L.   Furuta I.  

Oral Oncology, Vol. 40, Iss. 2, 2004-02 ,pp. : 164-169

Elsevier

Access to resources Recommend Favorite